Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × Costs and Cost Analysis × 1 year × Clear all

NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

Lymphoma, Large B-Cell, Diffuse